🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
We hypothesized that intra-arterial gemcitabine/oxaliplatin administered as...
Status
Recruiting
Location
Amiens University Hospital
Start Date
2018-06-11
Trial ID
NCT03364530
Treatments Being Tested
This is a multi-center, open-label, first-in-human Phase 1 study evaluating...
Status
Active Not Recruiting
Location
GSK Investigational Site
Start Date
2016-03-07
Trial ID
NCT02715284
Treatments Being Tested
This multicenter, prospective, randomized, controlled, open-label, two-arm ...
Status
Recruiting
Location
Jinan, Shandong 0531
Start Date
2025-07-21
Trial ID
NCT06841172
This study will be conducted in 2 parts. The first part is a phase 1 single...
Status
Recruiting
Location
City of Hope
Start Date
2023-09-13
Trial ID
NCT05797805
Treatments Being Tested
This research study is evaluating a drug called cabozantinib as a possible ...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2013-09
Trial ID
NCT01954745
Treatments Being Tested
A Phase 2, Multicenter, Open-Label Study of DKN-01 in Combination with Tisl...
Status
Terminated
Location
Mayo Clinic Cancer Center
Start Date
2020-07-29
Trial ID
NCT04363801
This study is designed to evaluate the safety, tolerability, PK, pharmacody...
Status
Recruiting
Location
Research Site
Start Date
2024-01-23
Trial ID
NCT06137144
Treatments Being Tested
This study will use real-world data to assess prevalence of brain metastase...
Status
Completed
Location
ConcertAI Database
Start Date
2024-03-01
Trial ID
NCT06557967
Treatments Being Tested
Doxorubicin has been an integral part of the treatment of women with breast...
Status
Completed
Location
NEA Baptist Clinic
Start Date
2009-12
Trial ID
NCT01033032
Treatments Being Tested
Given that pyrotinib has been proven to exert significant efficacy against ...
Status
Recruiting
Location
Peking University People's Hospital
Start Date
2026-07-06
Trial ID
NCT07600164
Treatments Being Tested